Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 811 results for "gilead sciences"

Breakthrough: Tablets Preventing HIV Virus Transmission Discovered
International Business Times Australia

Breakthrough: Tablets Preventing HIV Virus Transmission Discov...

A new tablet Truvada, made by Pharmaceutical Company Gilead Sciences, can prevent HIV virus transmission, according to a study published in Lancet, a medical journal. The participants in 2014's International AIDS Reuters Tablet Truvada (a ... International Business Times Australia, 1 hour ago

232 images for gilead sciences

American Banking News, 15 hours ago, 6 hours ago
BusinessWeek, 1 day ago
CNBC, 1 day ago
One News Page United Kingdom, 1 day ago
Waynesville Daily Guide, 8 hours ago, 6 days ago
MSN Money, 1 week ago, 2 weeks ago
BusinessWeek, 1 day ago
American Banking News

Why Gilead Stock's Newest Drug Approval Isn't a Gamechanger

Gilead Sciences ( NASDAQ: GILD ) is finally an oncology company. It's been years in the making . On Wednesday, the biotech got Zydelig approved to treat three different B-cell blood cancers: chronic lymphocytic leukemia, follicular B-cell ...
 Motley Fool2 hours ago Gilead Sciences Gets Positive CHMP Opinion For Zydelig - Quick Facts  RTTNews.com3 hours ago European CHMP Adopts Positive Opinion for Gilead's Zydelig┬« (idelalisib) for the Treatment of Chronic Lymphocytic Leukemia and Follicular Lymphoma  BusinessWeek3 hours ago Gilead Sciences annuncia i risultati finanziari registrati nel secondo trimestre dellesercizio 2014  Business Wire10 hours ago

Europe backs new leukemia drugs from J&J and Gilead

LONDON, July 25 (Reuters) - Two new leukemia drugs from Johnson & Johnson and Gilead Sciences have been recommended for approval by European regulators, paving the way for formal approval in a couple of months. The European Medicines Agency said ...
 CNBC3 hours ago Europe backs new leukaemia drugs from J&J and Gilead  London South East3 hours ago Company Update: Gilead Sciences Inc (NASDAQ:GILD) U.S. Food and Drug Administration Approves Gilead's Zydelig┬« (idelalisib) for Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small L  Wall Street Select1 day ago

Uptrend Call Working As Gilead Sciences Stock Rises 24.0% (GILD)

(SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Gilead Sciences (NASDAQ:GILD) on April 22nd, 2014 at $72.56. In approximately 3 months, Gilead Sciences has returned 23.99% as of today's recent price of $89.96. Gilead ...
 TradingCharts.com18 minutes ago

Gilead says EU Committee to recommend approval of leukemia drug

NEW YORK (MarketWatch) -- Gilead Sciences Inc. ( GILD ) said Friday that a key committee of the European Medicines Agency (EMA) is recommending that its Zydelig treatment for leukemia be approved for use in the 28 countries of the European Union.
 TD Ameritrade2 hours ago
Money Morning

Gilead Sciences - Sovaldi Momentum Continues, Appeal Remains

Summary Gilead reported blow-out second quarter results driven by Sovaldi of course. The full year outlook looks conservative, implying second half sales to drop. Despite risks related to pricing and competing drugs, the overall valuation remains ...
 Seeking Alpha1 day ago Update: Gilead Sciences Earnings  Seeking Alpha1 day ago Gilead beats forecasts as Sovaldi sales soar24-07-2014  Pharma Letter6 hours ago Gilead Stock's Great Expectations and Giant Opportunity  Motley Fool1 day ago

Gilead profit more than quadruples on hep C drug

Gilead Sciences Inc. on Wednesday reported profit that more than quadrupled in its second quarter, topping analysts' expectations on sales of its new breakthrough drug for hepatitis C. The company's performance was driven by explosive growth of ...
 Bioscience Technology Online21 hours ago Gilead Sciences 2nd-quarter net income more than quadruples  FOXBusiness.com1 day ago Gilead Sciences Q2 Profit Soars On Sovaldi Sales - Quick Facts  RTTNews.com1 day ago Gilead 2Q profit more than quadruples  Wall Street Business Network1 day ago
Bio Spectrum Asia

Gilead allows sublicense of HIV drug to generic firms

Singapore: HIV drug developer, Gilead Sciences has partnered with Medicines Patent Pool (MPP) to expand access to Gilead's investigational drug tenofovir alafenamide (TAF) for HIV and hepatitis B contingent on the medicine's US regulatory approval. ...
 Bio Spectrum Asia5 hours ago Gilead Announces New Agreement With MPP On HIV Experimental Drug  RTTNews.com1 day ago

Why Gilead Sciences, inc. Stock Was Flat Today

Gilead Sciences ( NASDAQ: GILD ) turned in an incredible quarter yesterday, with revenue of $6.5 billion beating analyst expectations by 12% and more than doubling the year-ago quarter. The difference in earnings was even starker: Adjusted EPS ...
 Motley Fool15 hours ago

What Gilead Stock's Latest Blockbuster Approval Means for Investors

Source: Gilead Sciences Gilead Sciences ( NASDAQ: GILD ) has won approval for its promising drug Zydelig in three important cancer indications. As a combination treatment alongside Roche's top selling Rituxan, the FDA green-light puts ...
 Motley Fool18 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - gilead sciences
Get updated on latest news & your favorite topics right in your inbox!
More     Less